MarketBeat on MSN

Black Diamond Therapeutics lung cancer drug shows 15.2-month PFS in phase 2 study

Black Diamond Therapeutics (NASDAQ:BDTX) reported updated Phase 2 data for silevertinib in treatment-naive non-small cell ...

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Preliminary mPFS of 15.2 months; mDOR not reachedRobust CNS activity, with 86% CNS ORR; no patients developed de novo brain metastasesORR 60% in ...

Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC

Webcast will be held Thursday, May 21, 2026, at 5:30 p.m. ET CAMBRIDGE, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company ...
Fox Business

Black diamond believed to be from outer space could fetch $6.8M at auction: ‘Exceptionally rare’

An extremely rare diamond believed to be from outer space will be going up for auction next month. Auction house Sotheby’s Dubai will be selling the 555.55-carat black diamond, known as "The Enigma," ...
Powder

Black Diamond Issues New Recall on Recon LT Avalanche Beacon

Check to see if your Black Diamond Recon LT Avalanche Transceiver is affected by this new recall. American backcountry and climbing safety equipment manufacturer Black Diamond has issued a product ...
Forbes

Enigma Black Diamond Sells For $4.3 Million At Auction

I am a Lifestyle reporter at Forbes, focusing on beauty & style. Feb 09, 2022, 11:30am EST Updated Feb 10, 2022, 08:37am EST The Enigma Diamond, at 555.55 carats, was unveiled at Sotheby's Dubai in ...

Black Diamond Therapeutics, Inc: Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations

Preliminary mPFS of 15.2 months; mDOR not reachedRobust CNS activity, with 86% CNS ORR; no patients developed de novo brain metastasesORR 60% in patients with a broad spectrum of EGFR-NCMs, including ...